We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Pennsylvania Risperdal Breast Verdict Stands, Cut To $680,000; Janssen To Appeal

(April 6, 2016, 11:54 AM EDT) -- PHILADELPHIA — Janssen Pharmaceuticals Inc. and Johnson & Johnson on April 1 said they will appeal a Risperdal gynecomastia verdict, even after the court on March 10 reduced the original $1.75...
To view the full article, register now.